Introduction
============

Cerebral oximetry, using near-infrared spectroscopy to measure cerebral tissue oxygen saturation (SctO~2~), is being increasingly used in the ICU. We hypothesized that if a patient becomes brain dead in the ICU, this must be reflected in SctO~2~values. This might help in the timing of invasive procedures such as angiography, sometimes necessary in the confirmation of brain death.

Methods
=======

We retrospectively analyzed the cerebral oximetry data of seven patients with severe TBI or diffuse cerebral edema who evolved to brain death while being treated in the ICU. Absolute SctO~2~values were continuously measured with ForeSight technology (Casmed) with sensors applied bilaterally to the forehead.

Results
=======

Three patients (one TBI and two SAH) with continuous ICP and SctO~2~monitoring suffered, despite maximal medical treatment, a sudden (over 1 to 3 hours) increase in mean ICP from 32 mmHg to 91 mmHg (equalization of ICP and MAP). Over the same time period, a parallel decrease in mean SctO~2~from 71% to 54% ICP was observed. One patient (cerebral edema after asphyxia) had continuous EEG and SctO~2~monitoring: a sharp decrease in SctO~2~from 67% to 56% over 30 minutes was accompanied by an increase in suppression ratio from 70% to 100%. The absence of cerebral blood flow was confirmed by CT angiography. One patient (cerebral edema after prolonged CPR) had only SctO~2~measurement for cerebral monitoring: during his stay in the ICU, there was a sudden decrease in SctO~2~from 64% to 54% over a 90-minute period. Shortly after this, the pupils became dilated and fixed. Brain death was confirmed by full EEG. Three brain-dead patients with documented absence of cerebral blood flow were monitored for SctO~2~during subsequent organ donation procedure: SctO~2~remained at a mean value of 59% during the procedure, and fell sharply only at the onset of circulatory arrest to reach a stable value of 25%.

Conclusion
==========

In this small cohort of patients, the onset of brain death was accompanied in all cases by a sharp and large decrease in SctO~2~from 67% to 55% (mean, *n*= 5) and remained stable. SctO~2~values only reached minimal values (25%, *n*= 3) at complete circulatory arrest. Our data suggest that SctO~2~measurement may be helpful in the timing of the diagnosis of brain death, especially in those patients without ICP or continuous EEG monitoring.
